Press Releases

e.l.f. is fueling the future of empowered.legendary.females. at the largest single-day sporting event in the world e.l.f. Cosmetics, a brand from e.l.f. Beauty (NYSE:ELF), the bold disruptor with a kind heart, is fueling its fourth season with professional race car driver Katherine Legge at the Indianapolis 500 (Indy 500) this May. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426140110/en/Katherine Legge after qualifying for her fourth Indianapolis 500 (2024), posting a four-lap average of 230.244 mph. Photo credit: Geoff Miller/LAT In a world where women receive just 1% of all sport sponsorships, account for only 4% of d

Alex Fitzpatrick Earns PGA TOUR CardMENLO PARK, Calif., April 26, 2026 /PRNewswire/ -- Protiviti Golf Brand Ambassador and professional golfer Matt Fitzpatrick continued his strong 2026 season with a victory at the Zurich Classic of New Orleans alongside his brother, Alex Fitzpatrick. The Fitzpatrick brothers delivered a composed and cohesive performance throughout the team-format event, completing rounds of 64-65-57-71 (-31). The win secured Alex Fitzpatrick his first PGA TOUR card, marking a significant milestone in his professional career. This marks Matt Fitzpatrick's third

Unlocking New Open Internet Content Environments for Global AdvertisersHONG KONG, April 26, 2026 /PRNewswire/ -- The Trade Desk (NASDAQ:TTD), a global leader in advertising technology, today announced that it has become the first-ever demand-side platform (DSP) partner for vertical short drama platform DramaBox, enabling advertisers to programmatically incorporate this fast-growing open internet content environment into their omnichannel media strategies. The partnership spans markets worldwide, helping global advertisers to achieve more efficient, measurable, and scalable audience reach in an increasingly fragmented attention landscape.As the open internet continues to evolve, digital conte

Organon stockholders to receive US$ 14.00 per share in cash The deal values Organon at EV of US$ 11.75 billion Combined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, "Sun Pharma") and Organon & Co. (NYSE:OGN) ("Organon") today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press r

Yesterday, FF successfully held the EAI Developer Ecosystem Forum and the strategic launch of the FF EAI Brain & Developer Platform in the San Francisco Bay Area, where the Company officially started recruiting co-builders for its developer ecosystem. BIBS (Boston International Business School) and FF have signed a MOU of strategic cooperation. The two parties plan to jointly establish the BIBS–FF AI and Robotics Institute and to hold a launch ceremony in early May at the University of Nebraska. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or the "Company"), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business

Approximately $565 million in new contract value since the January fleet status report, including 3-year extension for the Noble Courage and 5-well contract for the Noble Deliverer; backlog stands at $7.5 billion.$0.50 per share cash dividend declared for Q2, maintaining consistent return of capital program.Q1 Net Income of $121 million, Diluted Earnings per Share of $0.75, Adjusted Diluted Earnings per Share of $0.26, Adjusted EBITDA of $277 million, net cash provided by operating activities of $273 million, and Free Cash Flow of $169 million.Full Year 2026 Guidance for Revenue and Adjusted EBITDA maintained, 2026 capital expenditures guidance increased by $25 million due to the reactivatio

Conference call will take place on Monday, April 27, 2026 at 8:00 am ET Veradermics, Incorporated (NYSE:MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host an investor call and live webcast to review topline results from Part A of its randomized, double-blind, placebo-controlled Phase 2/3 ‘302' clinical trial evaluating VDPHL01, a proprietary extended-release oral minoxidil tablet, in males with mild-to-moderate pattern hair loss. Webcast Details: Time: Monday, April 27, 2026 at 8:00 a.m. ET. Joining: The event and the accompanying slides will be available on the Events p

Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and CHICAGO, April 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) today announced data supporting use of the company's FARAPULSE™ Pulsed Field Ablation (PFA) Platform and WATCHMAN™ Left Atrial Appendage Closure (LAAC) technologies. All data were presented at Heart Rhythm 2026, the annual meeting of the Heart Rhythm Society, held in Chicago from April 24-26. Results from the AVANT G

MENLO PARK, Calif., April 26, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, today announced it will report Week 16 data for ORKA-001 from the ongoing EVERLAST-A Phase 2a trial in moderate-to-severe plaque psoriasis on Monday, April 27, 2026. Following the announcement, the company will host a conference call and webcast at 8:00 a.m. ET to discuss the results. Webcast Details Oruka Therapeutics' live webcast of the EVERLAST-A results will begin on Monday, April 27th, at 8:00 a.m. ET. The live webcast can be accessed via

84% Freedom From Shock and 59% Freedom From VT Recurrence in FULCRUM-VT Pivotal IDE Trial Meet Safety and Effectiveness Endpoints and Replicate CryoCure-VT Results First and Only Ablation Technology to Show Equivalent Effectiveness Across Ischemic and Non-Ischemic Cardiomyopathy All From Endocardial Approach Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its FULCRUM-VT Investigational Device Exemption ("IDE") clinical trial, which will be used to support the Company's application for Food and Drug Administration ("FDA") Premarket

Multicenter results show sustained high durability and procedural efficiency, redefining positive expectations for catheter ablation in patients with atrial fibrillation Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking positive clinical data from its nPulse Cardiac Catheter System first-in-human feasibility study at the Heart Rhythm 2026 meeting. The late-breaking presentation included incremental participant follow up data. Building upon the previously reported data set presented at the AF Symposium meeting in February of 2026, the expanded 6-

Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's growing pulsed field ablation and novel cardiac pacing portfoliosSix-month results from the FlexPulse IDE study for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, reveal positive outcomes for treating complex AFib casesNew data from the Volt CE Mark Extension Cohort trial for the Volt™ PFA System, demonstrate the strong safety, efficacy and efficiency of treatment of AFib cases for posterior wall ablationTwo new conduction system pacing studies showcase initial results of Abbott's investigational UltiSynq™ CSP implantable cardioverter-defibrillator lead and a fi

HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of the Sphere-9 catheter for treatment of VT; U.S. pivotal trial approved by FDANew at HRS: data show consistent durability for the Sphere-360 catheter across patient anatomies; Sphere-360 approved in CE Mark geographiesFirst patients enrolled in Conquer-AF trial to evaluate the Sphere-9 catheter for repeat atrial fibrillation proceduresGALWAY, Ireland and CHICAGO, April 25, 2026 /PRNewswire/ -- Medtronic plc, (NYSE:MDT), a global leader in healthcare technology, today announc

GUANGZHOU, China, April 25, 2026 /PRNewswire/ -- Pony AI Inc. ("Pony.ai") (NASDAQ:PONY, HKEX: 2026)) today announced its new generation autonomous driving domain controller, a high-performance compute system designed for both Pony.ai's L4 autonomous driving platform and a broader set of customer applications across autonomous mobility. Developed in collaboration with NVIDIA, the new controller is built on the NVIDIA DRIVE Hyperion platform and powered by NVIDIA DRIVE AGX Thor with NVIDIA NVLink, supporting Pony.ai's next phase of commercialization in robotaxis and its growing domain controller business. The new system is designed to deliver significant gains in AI computing performance, ener

Cementos Pacasmayo S.A.A. and subsidiaries (NYSE:CPAC, BVL: CPACASC1)) ("the Company" or "Pacasmayo"), a leading cement company serving the Peruvian construction industry, announced today its consolidated results for the first quarter ("1Q26"). These results have been prepared in accordance with International Financial Reporting Standards ("IFRS") and are stated in Soles (S/). 1Q26 FINANCIAL AND OPERATIONAL HIGHLIGHTS: (All comparisons are to 1Q25, unless otherwise stated) Sales volume of cement, concrete and precast increased by 11.7%, mainly due to increased demand of cement and concrete. Revenues increased by 11.3%, in line with the increase in sales volume mentioned above.

For the 10th straight year, Forbes has named Banner Bank one of the 100 Best Banks in America based on the bank's financial strength, profitability and growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424497348/en/Banner Bank receives Forbes recognition for 10th straight year "Being recognized by Forbes year after year reflects the disciplined way we run our business and the strength of our balance sheet," said Mark Grescovich, Banner Bank President and CEO. "It reaffirms our approach to banking is on the mark—to remain a consistent, reliable source of capital and a trusted partner for the people and businesses we serve

LIMA, Peru, April 24, 2026 /PRNewswire/ -- Intercorp Financial Services Inc. ("IFS" or the "Company") (BVL/NYSE:IFS) announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 (the "2025 Annual Report") with the U.S. Securities and Exchange Commission (the "SEC"). With the filing of its 2025 Annual Report, the Company complies with its reporting obligations with the SEC and the New York Stock Exchange (NYSE).The 2025 Annual Report includes the audited consolidated financial statements of the Company in accordance with International Financial Reporting Standards (IFRS) as adopted by the International Accounting Standards Board and its auditors' op

Related Digital and Funds Affiliated with Blackstone Commit Equity to Fund Project; Fixed Rate, Long-Term Debt Financing Anchored by PIMCO-Managed Funds and AccountsCampus Creates Thousands of Union Construction Jobs and Significant Community Investment DALLAS, April 24, 2026 /PRNewswire/ -- Related Digital, a vertically integrated data center development and investment platform, and Blackstone (NYSE:BX) announced today that financing has been secured for Related Digital's $16 billion data center campus in Saline Township, Michigan, purpose-built for Oracle. The financing includes equity from Related Digital and funds affiliated with Blackstone, and fixed-rate, long term debt financing ancho

DENVER, April 24, 2026 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp., (NASDAQ:BANX) ("ArrowMark Financial"), today announced that BANX's estimated and unaudited Net Asset Value ("NAV") as of March 31, 2026, was $21.12. This estimated NAV is not a comprehensive statement of our financial condition or results for the month end. About ArrowMark Financial Corp. ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select Market under the symbol "BANX." Its investment objective is to provide shareholders with current income. BANX pursues its objective by investing primarily in regulatory capital securities of financial institutions. BANX i

MONTERREY, Mexico, April 24, 2026 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. ("FEMSA" or the "Company") (NYSE:FMX, BMV:FEMSAUBD, FEMSAUB)) has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (SEC) followed by its annual report, for the same period, with the Comisión Nacional Bancaria y de Valores (Mexican Banking and Securities Commission) and the Bolsa Mexicana de Valores (Mexican Stock Exchange). These reports are available on FEMSA's investor relations website at http://ir.femsa.com. Shareholders may receive a hard copy of the report, which includes FEMSA's audited financial statement